News
Keep calm: Under 25s with diabetes aren’t being hospitalized for COVID-19
March 26, 2020
But some are concerned that type 1 diabetes diagnoses are being delayed.
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
March 18, 2020
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2 inhibitors at a higher risk of ketoacidosis.
![1]()
News
Treating COVID-19 in patients with diabetes
March 17, 2020
Most health advisories about COVID-2019 mention diabetes as one of the high-risk categories for the disease.
News
COVID-19: Extra caution needed for patients with diabetes
March 17, 2020
Coexisting heart disease, kidney disease, advanced age, and frailty are likely to further increase the severity of disease.
News
Risk factors for death from COVID-19 identified in Wuhan patients
March 11, 2020
The odds of dying in the hospital increased with age, higher SOFA score, and D-dimer level exceeding 1 mcg/L.
News
MACE benefits with dapagliflozin improve with disease duration
March 4, 2020
Findings suggest treatment with the SGLT-2 inhibitor should be initiated early in some high-risk patients.
![1]()
News
Tools for preventing heart failure
February 13, 2020
SNOWMASS, COLO. – “There will be more than 1 million new cases of heart failure this year, and the vast majority of them could have been prevented.” – Gregg C. Fonarow, MD
![1]()
News
Noninjectable modes of insulin delivery coming of age
February 2, 2020
Intranasally delivered insulin may also improve neurocognitive function.
![1]()
News
Treatment of heart failure with preserved ejection fraction is a work in progress
January 13, 2020
Although the disorder has a lower mortality than heart failure with reduced ejection fraction, it places a significant burden on health care systems.
![1]()
News
Farxiga granted Priority Review for treatment of adults with HFrEF
January 6, 2020
The Food and Drug Administration is reviewing dapagliflozin for reducing the risk of cardiovascular death or worsening of heart failure in adults with heart failure with reduced ejection fraction based on DAPA-HF.
